Panacea Biotec share news, announcements and annual reports
NSE: PANACEABIOBSE: 531349Pharmaceuticals & BiotechnologySmall Cap
Panacea Biotec Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 1996 on BSE, Apr 1996 on NSE
Last close ₹313.25down ₹12.65 (3.88%)BSE ₹312.95
Share price at the NSE close on 30 Oct 2026. Previous close ₹325.90.
30 Oct: open ₹323.05, high ₹325.95, low ₹311.10
52-week range of traded prices to 30 Oct 2026
₹292.40Low, 30 Mar 2026₹647.00High, 9 Jun 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,919 Cr1,088th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.30
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −0.9%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹11 crore of one-off items, the largest of them in the quarter to Dec 2025.
- −2.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −3.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.03
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 57,86658.2% delivered
Panacea Biotec board meetings
135 filed, newest first. Page 2 of 3.
Sep 2020
3 Sep · Board meeting
Aug 2020
25 Aug · Board meeting
Jun 2020
29 Jun · Board meeting
Feb 2020
14 Feb · Board meeting
5 Feb · Board meeting
Nov 2019
14 Nov · Board meeting
Aug 2019
12 Aug · Board meeting
Jul 2019
31 Jul · Board meeting
May 2019
30 May · Board meeting
20 May · Board meeting
Feb 2019
26 Feb · Board meeting
21 Feb · Board meeting
14 Feb · Board meeting
5 Feb · Board meeting
Nov 2018
14 Nov · Board meeting
Aug 2018
14 Aug · Board meeting
3 Aug · Board meeting
May 2018
31 May · Board meeting
16 May · Board meeting
Mar 2018
12 Mar · Board meeting
Feb 2018
Nov 2017
Sep 2017
13 Sep · Board meeting
Aug 2017
May 2017
Jan 2017
Oct 2016
Jul 2016
May 2016
Feb 2016
Jan 2016
Oct 2015
Jul 2015
May 2015
28 May · Board meeting
Feb 2015
2 Feb · Board meeting
To inter-alia, consider and approve the Unaudited Financial Results (Provisional) for the quarter ended December 31, 2014.
Dec 2014
9 Dec · Board meeting
Board of Directors of the Company had, in its meeting held on December 09, 2014, inter-alia, decided, subject to the approval of shareholders, for issue of 0.5% Non-convertible Cumulative Redeemable Preference Shares of Rs.10/- each at par to the promoters and their relatives by way of conversion of existing unsecured loans / public deposits from them and/or fresh contribution in cash, aggregating to Rs.34.30 Crore towards promoter s contribution as per the terms of CDR-LOA dated 09.09.2014, subject to CDR Lenders agreeing to consider such Preference Shares as the promoters contribution. The Board had also decided that an Extra-ordinary General Meeting of the Company will be held on January 06, 2015.
Oct 2014
20 Oct · Board meeting
To inter-alia, consider and approve the Unaudited Financial Results (Provisional) for the quarter and half-year ended September 30, 2014.
Aug 2014
1 Aug · Board meeting
Board of Directors of the Company at its meeting held on August 01, 2014 has decided to raise funds by way of issue of equity share and/or other securities etc. aggregating upto Rs. 250 Crore or equivalent thereof in any currency, subject to approval of the Shareholders.
Jul 2014
23 Jul · Board meeting
To inter-alia, consider and approve the Unaudited Financial Results (Provisional) for the quarter ended June 30, 2014 and raising of funds by way of issue of securities aggregating upto Rs.250 Crore or equivalent thereof in any currency. The trading window of the Company shall remain closed for the promoters, directors, officers and designated employees of the Company from July 23, 2014 to August 02, 2014 (both days inclusive) in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 1992 read with the Company's Code of Conduct for Prevention of Insider Trading.
May 2014
31 May · Board meeting
Board of Directors of the Company at its meeting held on May 30, 2014 has considered the following items: (1) In view of non-availability of profits, no dividend has been recommended on the Equity Shares of the Company for the financial year ended March 31, 2014.31 May · Board meeting
Feb 2014
Jan 2014